arrow
F

Francesco Fiz

Department of Nuclear Medicine
H指数:24
被引数:2,020

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

[64Cu]CuCl2 as a Novel Metabolic Marker of Progression and Survival in Muscle-Invasive Bladder Cancer

[64Cu]CuCl2作为肌肉浸润性膀胱癌进展和生存的新型代谢标志物

2026-09-020
OAAI
CT-radiomics and pathological tumor response to systemic therapy: A predictive analysis for colorectal liver metastases. Development and internal validation of a clinical-radiomic model

Ct-radiomics和病理学肿瘤对全身治疗的反应: 结直肠癌肝转移的预测分析。临床影像组学模型的开发和内部验证

EJSO
IF2.9
2025-03-010
PRE
Personalised PET imaging in oncology: an umbrella review of meta-analyses to guide the appropriate radiopharmaceutical choice and indication

肿瘤学中的个性化PET成像: 荟萃分析的总括综述,以指导适当的放射性药物选择和适应症

2024-09-114
OAAI
Radiomic Gradient in Peritumoural Tissue of Liver Metastases: A Biomarker for Clinical Practice? Analysing Density, Entropy, and Uniformity Variations with Distance from the Tumour

肝转移肿瘤周围组织的影像学梯度: 临床实践的生物标志物?分析密度,熵和均匀性随距肿瘤距离的变化

2024-07-181
OAAI
ASO Visual Abstract: Radiomics of Intrahepatic Cholangiocarcinoma and Peritumoral Tissue Predicts Postoperative Survival: Development of a CT-Based Clinical-Radiomic Model

ASO视觉摘要: 肝内胆管细胞癌和肿瘤周围组织的影像组学预测术后生存: 基于CT的临床影像组学模型的开发

2024-07-090
PRE
Radiomics of Intrahepatic Cholangiocarcinoma and Peritumoral Tissue Predicts Postoperative Survival: Development of a CT-Based Clinical-Radiomic Model

肝内胆管癌和肿瘤周围组织的影像组学预测术后生存: 基于CT的临床影像组学模型的开发

2024-05-263
PRE
The evidence-based role of catecholaminergic PET tracers in Neuroblastoma. A systematic review and a head-to-head comparison with mIBG scintigraphy
2023-11-148
OAAI